CLINICAL_TRIALS
trial_result
· 2026-04-16
Clinical Trial Update: Lipid Management in Renal Transplant Recipients Using Evolocumab. [Phase 4]
Summary
A Phase 4 clinical trial evaluated evolocumab for lipid management in renal transplant recipients, with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Brigham and Women's Hospital | Conditions: Hyperlipidemias | Phase 4 | Status: COMPLETED | Results posted: 2026-04-16